Evidence map›Paper›PMID 34645668›Full record

ArticleLife science alliance2022

Differential impact of a dyskeratosis congenita mutation in TPP1 on mouse hematopoiesis and germline.

Jacqueline V Graniel, Kamlesh Bisht, Ann Friedman, James White, Eric Perkey, Ashley Vanderbeck, Alina Moroz, Léolène J Carrington, Joshua D Brandstadter, Frederick Allen and 10 more

Open access · goldAbstract read
In one paragraph

Article in Life science alliance, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.5field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. HeterozygousGenes & development · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 3 institutions in 1 country.

Jacqueline V GranielDepartment of Molecular, Cellular and Developmental Biology, University of Michigan, Ann Arbor, MI, USA.ORCID 0000-0002-0405-4159
Kamlesh BishtDepartment of Molecular, Cellular and Developmental Biology, University of Michigan, Ann Arbor, MI, USA.
Ann FriedmanDepartment of Internal Medicine, Michigan Medicine, Ann Arbor, MI, USA.ORCID 0000-0003-4915-4038
James WhiteDepartment of Human Genetics, University of Michigan, Ann Arbor, MI, USA.
Eric PerkeyMedical Scientist Training Program, University of Michigan, Ann Arbor, MI, USA.
Ashley VanderbeckDivision of Hematology/Oncology, Department of Medicine; Abramson Family Cancer Research Institute, University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA, USA.
Alina MorozDepartment of Pediatrics, Michigan Medicine, Ann Arbor, MI, USA.
Léolène J CarringtonDivision of Hematology/Oncology, Department of Medicine; Abramson Family Cancer Research Institute, University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA, USA.ORCID 0000-0002-7352-3270
Joshua D BrandstadterDivision of Hematology/Oncology, Department of Medicine; Abramson Family Cancer Research Institute, University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA, USA.ORCID 0000-0003-0652-5791
Frederick AllenDivision of Hematology/Oncology, Department of Medicine; Abramson Family Cancer Research Institute, University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA, USA.
Adrienne Niederriter ShamiMedical Scientist Training Program, University of Michigan, Ann Arbor, MI, USA.
Peedikayil ThomasDepartment of Human Genetics, University of Michigan, Ann Arbor, MI, USA.
Aniela CraytonDepartment of Pediatrics, Michigan Medicine, Ann Arbor, MI, USA.
Mariel ManzorDepartment of Pediatrics, Michigan Medicine, Ann Arbor, MI, USA.
Anna MychalowychDepartment of Pediatrics, Michigan Medicine, Ann Arbor, MI, USA.
Jennifer ChaseDepartment of Internal Medicine, Michigan Medicine, Ann Arbor, MI, USA.
Saher S HammoudDepartment of Human Genetics, University of Michigan, Ann Arbor, MI, USA.
Catherine E KeeganDepartment of Human Genetics, University of Michigan, Ann Arbor, MI, USA keeganc@med.umich.edu.ORCID 0000-0002-7780-6542
Ivan MaillardDivision of Hematology/Oncology, Department of Medicine; Abramson Family Cancer Research Institute, University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA, USA imaillar@pennmedicine.upenn.edu.ORCID 0000-0003-1312-6748
Jayakrishnan NandakumarDepartment of Molecular, Cellular and Developmental Biology, University of Michigan, Ann Arbor, MI, USA jknanda@umich.edu.ORCID 0000-0001-9146-2785
University of Michigan · USCancer Research Institute · USMichigan Medicine · US

Funding

XenograftP30CA046592 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Eric R. Fearon · 1988 to 2026
$178.2M
MICHIGAN MEDICAL SCIENTIST TRAINING PROGRAMT32GM007863 · NIGMS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI COLLINS, KATHLEEN L. · 1985 to 2024
$38.3M
HEMATOLOGY CLINICAL RESEARCH TRAINING PROGRAMT32HL007439 · NHLBI · UNIVERSITY OF PENNSYLVANIA · PI LAWRENCE F BRASS, PETER S KLEIN · 1985 to 2026
$17.1M
IMMUNOBIOLOGY OF NORMAL AND NEOPLASTIC LYMPHOCYTEST32CA009140 · NCI · UNIVERSITY OF PENNSYLVANIA · PI Malay Haldar, WARREN S PEAR · 1985 to 2026
$16.1M
Research Training in BiogerontologyT32AG000114 · NIA · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI SCOTT PLETCHER · 1985 to 2026
$12.4M
University of Michigan Postbaccalaureate Research Education Program (UM PREP)R25GM086262 · NIGMS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI ALLEN, BENJAMIN · 2009 to 2024
$6.1M
VMD-PhD Training in Infectious Disease-Related ResearchT32AI070077 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI Michael Lee Atchison · 2008 to 2026
$3.5M
Contributions of Sperm Chromatin to development: A Myth or Reality?DP2HD091949 · NICHD · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI HAMMOUD, SAHER SUE · 2016 to 2016
$2.3M
Career Training in Reproductive BiologyT32HD079342 · NICHD · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Suzanne M MOENTER · 2014 to 2026
$2.3M
Molecular functions of the shelterin component ACD/TPP1 in somatic stem cells and tissue homeostasisR01AG050509 · NIA · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI KEEGAN, CATHERINE ELIZABETH, MAILLARD, IVAN · 2015 to 2019
$2.3M
Telomeric Protein Function and RegulationR01GM120094 · NIGMS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI NANDAKUMAR, JAYAKRISHNAN · 2016 to 2020
$1.5M
Improving Fertility Preservation in Boys with CancerR01HD092084 · NICHD · MAGEE-WOMEN'S RES INST AND FOUNDATION · PI ORWIG, KYLE EDWIN · 2017 to 2019
$1.1M
NCI NIH HHS P30 CA046592NCI NIH HHS T32 CA009140NHLBI NIH HHS T32 HL007439NIAID NIH HHS F30 AI136315NIAID NIH HHS T32 AI070077NIA NIH HHS R01 AG050509NIA NIH HHS T32 AG000114NICHD NIH HHS DP2 HD091949NICHD NIH HHS F30 HD097961NICHD NIH HHS R01 HD092084NICHD NIH HHS T32 HD079342NIGMS NIH HHS R01 GM120094NIGMS NIH HHS R25 GM086262NIGMS NIH HHS T32 GM007863
6 · The paper itself

Abstract

Telomerase extends chromosome ends in somatic and germline stem cells to ensure continued proliferation. Mutations in genes critical for telomerase function result in telomeropathies such as dyskeratosis congenita, frequently resulting in spontaneous bone marrow failure. A dyskeratosis congenita mutation in TPP1 (K170∆) that specifically compromises telomerase recruitment to telomeres is a valuable tool to evaluate telomerase-dependent telomere length maintenance in mice. We used CRISPR-Cas9 to generate a mouse knocked in for the equivalent of the TPP1 K170∆ mutation (TPP1 K82∆) and investigated both its hematopoietic and germline compartments in unprecedented detail. TPP1 K82∆ caused progressive telomere erosion with increasing generation number but did not induce steady-state hematopoietic defects. Strikingly, K82∆ caused mouse infertility, consistent with gross morphological defects in the testis and sperm, the appearance of dysfunctional seminiferous tubules, and a decrease in germ cells. Intriguingly, both TPP1 K82∆ mice and previously characterized telomerase knockout mice show no spontaneous bone marrow failure but rather succumb to infertility at steady-state. We speculate that telomere length maintenance contributes differently to the evolutionary fitness of humans and mice.

Indexed as

MutationAmino Acid SequenceAnimalsCRISPR-Cas SystemsDyskeratosis CongenitaFertilityGene EditingGerm CellsHematopoiesisHomozygoteHumansLymphopoiesisMaleMiceMice, KnockoutModels, MolecularAcd protein, mouseTelomere-Binding Proteins

Identifiers

PMID34645668
PMCPMC8548261
OpenAlexW3204988656

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.